Hospital exposure the source of XDR-TB infections, underlining the need for adequate infection control
HIV and TB in Practice for nurses: Drug-resistant TB
Aggressive therapy for MDR-TB reduces risk of disease recurrence
FDA Advisory Committee recommends accelerated approval of bedaquiline for drug-resistant TB
HIV is a risk factor for acquired resistance to key second-line anti-TB drugs
International study finds "worrying" levels of XDR-TB
HIV infection does not compromise multidrug-resistant TB treatment outcomes in Botswana
